| scholarly article | Q13442814 |
| P2093 | author name string | C Pfeiffer | |
| C Günther | |||
| M Meurer | |||
| G Wozel | |||
| P2860 | cites work | Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines | Q24321667 |
| Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody | Q24561853 | ||
| CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 | Q28190115 | ||
| Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia | Q28275791 | ||
| Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation. | Q33291059 | ||
| IL-4 induces eotaxin in human dermal fibroblasts | Q33755895 | ||
| Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. | Q33768110 | ||
| First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening. | Q33809888 | ||
| 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen | Q34143851 | ||
| Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines | Q79747218 | ||
| Serum chemokine profile in patients with bullous pemphigoid | Q79774023 | ||
| Differentiation of patients with leprosy from non-infected individuals by the chemokine eotaxin/CCL11 | Q81163048 | ||
| Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): a proposed mechanism of action | Q82672152 | ||
| CCL18 is expressed in patients with bullous pemphigoid and parallels disease course | Q83140582 | ||
| Seric chemokines and chemokine receptors in eosinophils during acute human schistosomiasis mansoni | Q84767299 | ||
| Bullous pemphigoid: end of the century overview | Q34480487 | ||
| Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. | Q34657104 | ||
| Basement zone antibodies in bullous pemphigoid | Q34696758 | ||
| Eotaxins and CCR3 Receptor in Inflammatory and Allergic Skin Diseases: Therapeutical Implications | Q35560567 | ||
| Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. | Q35774298 | ||
| C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation | Q36364952 | ||
| Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma | Q36955887 | ||
| The pathophysiology of bullous pemphigoid | Q37038481 | ||
| A major role for neutrophils in experimental bullous pemphigoid. | Q37372091 | ||
| The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow | Q37381694 | ||
| Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes | Q39942787 | ||
| Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells | Q40393129 | ||
| Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter | Q40641443 | ||
| Regional variations in antigenic properties of skin. A possible cause for disease-specific distribution of skin lesions | Q41904388 | ||
| Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy | Q42458243 | ||
| Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid | Q43800832 | ||
| Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization | Q44650821 | ||
| Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma | Q46667235 | ||
| Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid. | Q47278811 | ||
| High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells | Q47320455 | ||
| Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge | Q47620065 | ||
| Endothelial cells modulate eosinophil surface markers and mediator release | Q47847418 | ||
| Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. | Q47897154 | ||
| A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils | Q47945215 | ||
| Expression of adhesion molecules in allergic lung diseases. | Q51719979 | ||
| Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3. | Q53079307 | ||
| C-C Chemokine Receptor 3 Antagonism by the -Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap | Q57130759 | ||
| Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity | Q61628436 | ||
| The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers. | Q65000419 | ||
| Possible release of eosinophil granule proteins in response to signaling from intercellular adhesion molecule-1 and its ligands | Q71719293 | ||
| High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid | Q73005281 | ||
| Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid | Q73070660 | ||
| Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease | Q73673975 | ||
| CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro | Q74183206 | ||
| Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha | Q74243638 | ||
| Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL5, but not fMLP-prestimulated human peripheral blood eosinophils | Q74485132 | ||
| Tissue eosinophilia in pemphigoid gestationis: association with eotaxin and upregulated activation markers on transmigrated eosinophils | Q75269924 | ||
| Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy | Q77374863 | ||
| Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid | Q77542234 | ||
| Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration | Q77716087 | ||
| Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris | Q77828877 | ||
| BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid | Q78550547 | ||
| Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis | Q79293315 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bullous pemphigoid | Q1004647 |
| P304 | page(s) | 145-153 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid | |
| P478 | volume | 166 |
| Q47105853 | BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid |
| Q98778894 | CCL26 regulates the proportion of CD4+CD25+FOXP3+ Tregs and the production of inflammatory factors in peripheral blood mononuclear cells following acute ischemic stroke via the STAT5 pathway |
| Q37369596 | Circulating chemokine ligand levels before and after successful kidney transplantation |
| Q55154455 | Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients. |
| Q50771294 | Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways. |
| Q60962966 | Pathogenese der Prurigo nodularis |
| Q91811509 | Proteases in Pemphigoid Diseases |
| Q92479184 | Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin |
| Q90455736 | The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease |
Search more.